# Dyne Therapeutics, Inc.: Form 8-K, filed Dec 3, 2021

- Company: [Dyne Therapeutics, Inc.](/companies/dyn.md) (CIK 1818794)
- Form: 8-K
- Filed: 2021-12-03
- Accepted by EDGAR: Dec 2, 2021, 18:37 ET
- Period: 2021-12-02
- Accession: 0001193125-21-346916
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818794/000119312521346916/d204123d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818794/000119312521346916/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818794/000119312521346916/d204123d8k.htm

Filed Dec 3, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-346916. Last ingested by Listed: Nov 14, 2026, 19:07 ET. No prices; not investment advice.
